Inhwa Hwang

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Loss of astrocytic Bmal1 promotes blood-brain barrier disruption and synaptic dysfunction during systemic inflammation.

Loss of astrocytic Bmal1 promotes blood-brain barrier disruption and synaptic dysfunction during systemic inflammation.

Journal: Journal of neuroinflammation

Published: November 11, 2025

Author Correction: SGK1 inhibition in glia ameliorates pathologies and symptoms in Parkinson disease animal models.

Author Correction: SGK1 inhibition in glia ameliorates pathologies and symptoms in Parkinson disease animal models.

Journal: EMBO molecular medicine

Published: August 11, 2025

Type I interferon signaling promotes kainic acid-induced seizures through mTOR activation.

Type I interferon signaling promotes kainic acid-induced seizures through mTOR activation.

Journal: Neuropharmacology

Published: May 18, 2025

Microglial NLRP3-gasdermin D activation impairs blood-brain barrier integrity through interleukin-1β-independent neutrophil chemotaxis upon peripheral inflammation in mice.

Microglial NLRP3-gasdermin D activation impairs blood-brain barrier integrity through interleukin-1β-independent neutrophil chemotaxis upon peripheral inflammation in mice.

Journal: Nature communications

Published: April 09, 2024

Hyperglycemia enhances brain susceptibility to lipopolysaccharide-induced neuroinflammation via astrocyte reprogramming.

Hyperglycemia enhances brain susceptibility to lipopolysaccharide-induced neuroinflammation via astrocyte reprogramming.

Journal: Journal of neuroinflammation

Published: December 17, 2023

Deficiency of circadian clock gene Bmal1 exacerbates noncanonical inflammasome-mediated pyroptosis and lethality via Rev-erbα-C/EBPβ-SAA1 axis.

Deficiency of circadian clock gene Bmal1 exacerbates noncanonical inflammasome-mediated pyroptosis and lethality via Rev-erbα-C/EBPβ-SAA1 axis.

Journal: Experimental & molecular medicine

Published: May 15, 2023

Extracellular Acidification Augments NLRP3-Mediated Inflammasome Signaling in Macrophages.

Extracellular Acidification Augments NLRP3-Mediated Inflammasome Signaling in Macrophages.

Journal: Immune network

Published: September 27, 2022

Design and synthesis of an N-benzyl 5-(4-sulfamoylbenzylidene-2-thioxothiazolidin-4-one scaffold as a novel NLRP3 inflammasome inhibitor.

Design and synthesis of an N-benzyl 5-(4-sulfamoylbenzylidene-2-thioxothiazolidin-4-one scaffold as a novel NLRP3 inflammasome inhibitor.

Journal: Bioorganic & medicinal chemistry letters

Published: January 26, 2022

Therapeutic effect of NLRP3 inhibition on hearing loss induced by systemic inflammation in a CAPS-associated mouse model.

Therapeutic effect of NLRP3 inhibition on hearing loss induced by systemic inflammation in a CAPS-associated mouse model.

Journal: EBioMedicine

Published: January 25, 2022

Intracellular NAD+ Depletion Confers a Priming Signal for NLRP3 Inflammasome Activation.

Intracellular NAD+ Depletion Confers a Priming Signal for NLRP3 Inflammasome Activation.

Journal: Frontiers in immunology

Published: August 27, 2021

Neutrophils Facilitate Prolonged Inflammasome Response in the DAMP-Rich Inflammatory Milieu.

Neutrophils Facilitate Prolonged Inflammasome Response in the DAMP-Rich Inflammatory Milieu.

Journal: Frontiers in immunology

Published: July 23, 2021

Antimicrobial Peptide LL-37 Drives Rosacea-Like Skin Inflammation in an NLRP3-Dependent Manner.

Antimicrobial Peptide LL-37 Drives Rosacea-Like Skin Inflammation in an NLRP3-Dependent Manner.

Journal: The Journal of investigative dermatology

Published: October 26, 2020

Showing 1-12 of 32

Last Updated: 09/26/2026